Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis
Abstract Introduction New oral anticoagulants (NOACs) are approved for use in nonvalvular atrial fibrillation (AF). Objectives This study aimed to evaluate the efficacy and safety of NOACs compared with warfarin in AF and valvular heart disease (VHD). Methods We identified randomized controlled tria...
Main Authors: | Yasmin de Souza Lima Bitar, Mansueto Gomes Neto, Jose Admirço Lima Filho, Larissa Vitória Pereira, Kethyren Santos Oliveira Travassos, Kevan M. Akrami, Leonardo Roever, Andre Rodrigues Duraes |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2019-05-01
|
Series: | Drugs in R&D |
Online Access: | http://link.springer.com/article/10.1007/s40268-019-0274-z |
Similar Items
-
Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Yasmin de Souza Lima Bitar, et al.
Published: (2021-09-01) -
Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation
by: Alexander Birkinshaw, et al.
Published: (2020-03-01) -
Anticoagulation Control with Acenocoumarol or Warfarin in Non-Valvular Atrial Fibrillation in Primary Care (Fantas-TIC Study)
by: M. Rosa Dalmau Llorca, et al.
Published: (2021-05-01) -
The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01) -
Newer Anticoagulants for Non-Valvular Atrial Fibrillation
by: Joseph M. Harburger, et al.
Published: (2012-05-01)